These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17100982)

  • 21. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
    Husebye E; Tøn H; Johne B
    Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis.
    Varela E; Manichanh C; Gallart M; Torrejón A; Borruel N; Casellas F; Guarner F; Antolin M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):151-61. PubMed ID: 23725320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.
    Casellas F; Borruel N; Torrejón A; Varela E; Antolin M; Guarner F; Malagelada JR
    Aliment Pharmacol Ther; 2007 May; 25(9):1061-7. PubMed ID: 17439507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
    Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinuclear neutrophil antibodies are not markers for genetic susceptibility or indicators of genetic heterogeneity in familial ulcerative colitis.
    Achkar JP; Barmada MM; Duerr RH
    Am J Gastroenterol; 2002 Sep; 97(9):2343-9. PubMed ID: 12358254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
    Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
    J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
    Xiang JY; Ouyang Q; Li GD; Xiao NP
    World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
    Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
    Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
    Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population.
    Chen CC; Isomoto H; Narumi Y; Sato K; Oishi Y; Kobayashi T; Yanagihara K; Mizuta Y; Kohno S; Tsukamoto K
    Clin Immunol; 2008 Feb; 126(2):165-71. PubMed ID: 17980669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan.
    Kitahora T; Utsunomiya T; Yokota A
    J Gastroenterol; 1995 Nov; 30 Suppl 8():5-8. PubMed ID: 8563890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.
    Montalto M; Gallo A; Ferrulli A; Visca D; Campobasso E; Cardone S; D'Onofrio F; Santoro L; Covino M; Mirijello A; Leggio L; Gasbarrini G; Addolorato G
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):76-80. PubMed ID: 21030869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
    Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal calprotectin in very low birth weight infants.
    Josefsson S; Bunn SK; Domellöf M
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):407-13. PubMed ID: 17414135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
    Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
    Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.